(Q80363820)

English

Cost Effectiveness of Controlled-Release Oxybutynin Compared with Immediate-Release Oxybutynin and Tolterodine in the Treatment of Overactive Bladder in the UK, France and Austria

scientific article published on 01 January 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Cost Effectiveness of Controlled-Release Oxybutynin Compared with Immediate-Release Oxybutynin and Tolterodine in the Treatment of Overactive Bladder in the UK, France and Austria (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

0 references

author name string

Julian F Guest

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Dele Abegunde

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Francis J Ruiz

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

305-321

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Evaluation of a new once-daily formulation of oxbutynin for the treatment of urinary urge incontinence. Ditropan XL Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The standardization of terminology of lower urinary tract function

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolterodine use for symptoms of overactive bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of overactive bladder: long-term tolerability and efficacy of tolterodine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trospium chloride--an effective drug in the treatment of overactive bladder and detrusor hyperreflexia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Willingness to pay for reduced incontinence symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost of schizophrenia to UK Society. An incidence-based cost-of-illness model for the first 5 years following diagnosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bladder-sphincter biofeedback as treatment of detrusor instability in women who failed to respond to oxybutynin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immediate-release oxybutynin versus tolterodine in detrusor overactivity: a population analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Assessment of effectiveness of and tolerance to oxybutynin in the treatment of unstable bladder in women]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The quality of life in women with urinary incontinence as measured by the sickness impact profile

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urinary incontinence in the elderly. Causes and treatment options

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended-release oxybutynin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined behavioral and drug therapy for urge incontinence in older women

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The annual societal cost of alcohol misuse in Scotland

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National public health policies for prevention and care in urinary incontinence in the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of new treatments for overactive bladder: the example of tolterodine, a new muscarinic agent: a Markov model

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness and quality of life considerations in the treatment of patients with overactive bladder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic costs of urinary incontinence in 1995.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Burch-Cooper's ligament sling procedure: an augmented incontinence operation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of the quality-of-life aspects of urinary urge incontinence

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urinary incontinence in both sexes: prevalence rates and impact on quality of life and sexual life

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Behavioral vs Drug Treatment for Urge Urinary Incontinence in Older Women

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Annual cost of erectile dysfunction to UK Society

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized controlled trial comparing the efficacy of controlled-release oxybutynin tablets (10 mg once daily) with conventional oxybutynin tablets (5 mg twice daily) in patients whose symptoms were stabilized on 5 mg twice daily of oxybutynin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life and urinary incontinence.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. The Ditropan XL Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose oxybutynin for the treatment of urge incontinence: good efficacy and few side effects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/17516718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200424060-00001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17516718%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80363820&oldid=1752251550"